TRICARE Pharmacy Program RFI (Draft Section C & H)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) is in the acquisition planning phase for the next generation TRICARE Pharmacy Program (TPharm6) contract. This is a Special Notice / Request for Information (RFI) seeking industry feedback on draft Section C (Statement of Work) and Section H (Special Contract Requirements) documents. The Government invites qualified vendors to submit feedback and questions, and to participate in one-on-one meetings. Feedback and meeting requests are due by May 11, 2026, at 12:00 PM Mountain Time.
Scope of Work
The draft Section C, Statement of Work, outlines requirements for administering the TRICARE Pharmacy Benefits Program, serving approximately 9.5 million beneficiaries. Key responsibilities include:
- Efficient and accurate processing of claims from various sources (retail, TMOP, MTFs, VA, IHS).
- Administering a retail pharmacy network across the U.S. and its territories.
- Operating the TRICARE Mail Order Pharmacy (TMOP), including dispensing and delivery.
- Performing clinical reviews and providing beneficiary/pharmacy support services.
- Managing systems and interfaces (DEERS, PDW, Federal EHR).
- Handling specialty agents, vaccines, and compound prescriptions.
- Ensuring compliance with relevant regulations and DoD benefit design rules. Performance standards include 99.5% claims processing system availability, timely reimbursement processing, and specific call center metrics.
Special Contract Requirements
The draft Section H, Special Contract Requirements, details critical aspects such as:
- Organizational Conflicts of Interest (OCI): Requires contractors to avoid, mitigate, or neutralize OCIs, disclose affiliated pharmacies, and protect proprietary information.
- Cost Control Incentives: Outlines various incentives for retail network, specialty, and Market Priced Pharmaceutical Program (MPPP) based on cost savings and guaranteed pricing.
- Performance Guarantees: Establishes financial penalties for non-compliance across areas like Mail Order Pharmacy Prescription Processing, System Availability, Clinical Review Processing, Telephone Service, and Claims Compliance.
- Claims Compliance and Accuracy Reviews: Describes the Government's process for quarterly and annual retrospective reviews of claims data to identify errors, with target error rates for payment and occurrence.
- Other Requirements: Includes enhanced safeguarding for unclassified information, pilots, demonstrations, and Integrated Product Teams (IPTs).
Feedback Mechanism & One-on-One Meetings
Vendors are encouraged to use the provided TPharm6 feedback document.xlsx to submit comments, questions, or discussions related to specific sections (C or H) or general feedback. The DHA will facilitate one-on-one meetings in summer 2026 to gather additional feedback. Requests for these meetings must be submitted via a provided link.
Contract & Timeline
- Opportunity Type: Special Notice (RFI)
- Product Service Code: Q201 - Medical Managed Healthcare
- Department/Agency: DEPT OF DEFENSE / DEFENSE HEALTH AGENCY (DHA)
- Response Due: May 11, 2026, at 12:00 PM Mountain Time
- Published Date: April 9, 2026
- Set-Aside: None specified (RFI stage)
Contact Information
- Primary: Viktoria Reed (viktoriya.s.reed.civ@health.mil, 303-676-3648)
- Secondary: Brooke Wolfe (brooke.a.wolfe.civ@health.mil, 303-676-3799)